SII-ONCO-BCG (BACILLUS CALMETTE-GUERIN) Price

Dosage Form	Reg. No	Pack Size	Trade Price (TP)	Maximum Retail Price (MRP)
Inj	053818	1 Vial	—	—

📋 Indications & Clinical Dosage

*Bladder instillation for the treatment of primary or recurrent bladder carcinoma and for the prevention of recurrence following transurethral resection:* BY INTRAVESICAL INSTILLATION: Adult: (consult product literature)

⛔ Contraindications

Fever of unknown origin, HIV infection, impaired immune response, severe haematuria, tuberculosis, urinary-tract infection

⚠️ Precautions & Warnings

In case of bladder injury or traumatic catheterisation or urethral injury; delay administration until such mucosal damages healed. Should not be administered IV or SC or IM before the first intravesical instillation. Perform adequate screening for active tuberculosis and/or HIV prior to therapy.

⚠️ Adverse Reactions / Side Effects

Cystitis, dysuria, fever, haematuria, influenza-like syndrome, malaise, ocular symptoms, systemic BCG infection (with fatalities); consult product literature, urinary frequency. Rare: Arthralgia, bladder contracture, hypersensitivity reactions, orchitis, rash, renal abscess, transient urethral obstruction

🤰 Pregnancy & Lactation Safety

Pregnancy Risk:

Contraindicated

Lactation / Breastfeeding:

Contraindicated. Discontinue breast-feeding

📚 Official Regulatory & Clinical References

Drug Regulatory Authority of Pakistan (DRAP): Drug Registration, S.R.O. Price Gazettes & National Essential Medicines List (NEML).
World Health Organization (WHO): Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index).
Formulary Standards: British National Formulary (BNF) & Pakistan National Formulary (PNF) guidelines.